Prof. Volkmar Weissig: Editor in Chief at the "Journal of Mitochondria, Plastids and Endosymbiosis"
We would like to anounce that the president of WMS, Prof. Volkmar Weissig, is now serving as one Editor-in-Chief in the new journal by Taylor & Francis "Journal of Mitochondria, Plastids and Endosymbiosis" along with Prof. Dario Leister, Munich, Germany.
We also mention the associate editors:
Prof. Alessandro Prigione - Heinrich Heine University, Germany
Prof. Alisdair Fernie - Max Planck Insitute of Plant Physiology, Germany
Prof. Kelvin Yen - Leonard Davis School of Gerontology, USA
Prof. Marvin Edeas - Université de Paris, INSERM, France
Prof. Sally Mackenzie - Penn State, Huck Insitutes of Life Sciences, USA
Prof. Virginia Weis - Oregon State, USA
Prof. Vyacheslav Jurchenko - University of Ostrava, Czechia
Prof. Christian Schmitz-Linneweber - Humboldt Univeritat zu Berlin, Germany
Prof. Toshiharu Shikanai - Kyoto University, Japan
Prof Iris Finkemeier - WWU Münster, Germany
This journal is dedicated to serving the biology community by publishing novel and exciting findings with high significance in the biology of mitochondria, plastids and endosymbiosis. It focuses broadly on cellular biology, physiology, biochemistry, molecular biology, genetics, development, genomics, biomedicine, pharmacology, toxicology, bioinformatics, and molecular evolution, as well as on organismic interactions relevant in the context of endosymbiosis. Prof. Weissig will be covering the mitochondria in the endosymbiotic journal section.
Prof. Marvin Edeas, Founder of WMS, Université de Paris, INSERM, stated that: "The World Mitochondria Society will try to connect tightly with the Journal of Mitochondria, Plastids and Endosymbiosis to disseminate the meetings information and activities".
The journal is now open for submission. You can find more details here.
Professor Vladimir Skulachev, 87 years old – All our Condolences
Sad news came from Russia. On February 5, prominent scientist Academician Vladimir Skulachev passed away at the age of 87. He was internationally renowned and highly respected mitochondriologist because of his groundbreaking research in bioenergetics.
Vladimir Skulachev graduated from the biology and soil faculty of Moscow State University (1957), where he has been working since 1960. In 1961 he defended his Ph.D. thesis "The ratio of oxidation and phosphorylation in the respiratory chain."
In 1965-1973 he was the head of the bioenergy department of the Interfaculty Laboratory of Bioorganic Chemistry, since 1973 he was the head of the Laboratory of Bioorganic Chemistry.
In 1991, he became the Director of the Institute of Physical and Chemical Biology named after Belozersky.
In 2002, he founded the Faculty of Bioengineering and Bioinformatics at the Moscow State University and has been its dean to this day.
Among his scientific interests were the mechanisms of biological oxidation, transformation of chemical energy into electrical energy on mitochondrial membranes, the role of membrane potential as a factor conjugating the release and accumulation of energy in the cell. Since 2005, he has been leading a project to create a geroprotector drug based on mitochondria-targeted antioxidants.
Vladimir Skulachev, together with Efim Lieberman, obtained one of the first experimental proofs of the Mitchell’s chemiosmotic theory (Skulachev V.P., Sharaf A.A., and Liberman E.A. // Nature. 1967. V.216. N.5116. P.718-719). Using lipophilic cations and anions, they showed that energized mitochondria can accumulate cations, while submitochondrial particles, anions. In addition to the importance of the results obtained, in this work, the term "protonophore" was first introduced into the scientific literature, which is successfully used to this day. This publication was received with great interest by the scientific community and in recognition of its importance, these ions were named "Skulachev ions” by the famous American biochemist David Green. For this work, in 1975 Vladimir Skulachev was awarded the State Prize of the USSR.
Vladimir Skulachev was a Full member of the Russian Academy of Natural Sciences, member of the European Academy and president of the club of its Russian members, president of the All-Russian Biochemical Society, honorary president of the All-Russian Society of Biochemists and Molecular Biologists, full member of the Academy of Creativity; doctor honoris causa of Vilnius University.
From the first Congress “Targeting mitochondria” in the year 2010, he was a member of the scientific committee and its regular speaker. He regularly took part in the World Mitochondria Society's strategic discussions about the future of mitochondria in health and the strategies on how to progress in this subtle field.
On behalf of the WMS, Volkmar Weissig (President), Marvin Edeas (Founder), and Vladimir Gogvadze (Chairman of the board), we share our all sadness and sympathy with his family and colleagues.
The next meeting on Targeting Mitochondria will be dedicated to Professor Skulachev's legacy in the world of mitochondria.
Steigenberger Hotel Am Kanzleramt: Venue of Targeting Mitochondria 2023
The 14th World Congress on Targeting Mitochondria on October 11-13, 2023 in
Steigenberger Hotel Am Kanzleramt
Ella-Trebe-Straße 5
10557 Berlin, Germany
- Via email on This email address is being protected from spambots. You need JavaScript enabled to view it.
- By phone: +49 30 740 743 990
- Or by fax: +49 30 740 743 816
You can let them know that you are attending Targeting Mitochondria 2023. You can also use the code "WMS2023" in your communication with them.
World Mitochondria Society
14th Targeting Mitochondria 2023 Congress
October 11-13, 2023 - Berlin, Germany
www.wms-site.com
Winner of the Best Mitochondria Image 2022: Erminia Donnarumma, Institut Pasteur
The World Mitochondria Society congratulates the winner of the Best Mitochondria Image 2022 Erminia Donnarumma, Institut Pasteur, France. Her image entitled "Mitochondria run parallel in mature cardiomyocytes" shows: Adult primary cardiomyocytes (mouse) stained with TMRE (mitochondria, orange) and NucBlue (nuclei, blue).
Dr. Donnarumma performed her PhD (2012-2015) in Pharmaceutical Sciences between the University of Naples Federico II in Italy and the Cardiovascular Center of Excellence in New Orleans (USA). Her work focused on the identification of new medications that could act or improve the crosstalk between the hydrogen sulfide (H2S) and nitric oxide (NO) signaling in small and large animal models of heart failure induced by myocardial ischemia and reperfusion injury. After this time, she nucleated my interest in mitochondria as therapeutic target in cardiac diseases. She therefore moved to France in 2016 to join the Wai Lab at the Institut Pasteur.
Dr. Donnarumma stated: "The main focus of my work was to investigate the role of Mitochondrial Fission Process 1 (MTFP1) in mitochondrial dynamics and the heart homeostasis. I discovered that MTFP1 loss in cardiomyocytes impairs mitochondrial inner membrane integrity leading to impaired mitochondrial bioenergetics, cardiomyocyte death and inflammatory dilated cardiomyopathy. My on-going and future researches aim at the understanding how mitochondria trigger inflammation in cardiomyocytes and the relevance of the sex bias that exists at the level of mitochondria for the development of sex- specific cardiac diseases".
You will be able to submit your images for #BestMitochondriaImageContest 2023 shortly.
World Mitochondria Society
14th Targeting Mitochondria 2023 Congress
October 11-13, 2023 - Berlin, Germany
LinkedIn | Facebook
Personalized Medicine in Mitochondrial Health and Disease: Myth and Reality
Prof. Ciro Leonardo Pierri from the University of Bari, Italy, will join the 14th edition of the World Conference on Targeting Mitochondria 2023, held in Berlin, Germany, from October 11th to 13th. In this conference, Prof. Pierri will give a talk entitled "Personalized Medicine in Mitochondrial Health and Disease: Myth and Reality.
Mitochondrial diseases may result from mutations affecting nuclear or mitochondrial genes, encoding mitochondrial proteins, or non-protein coding mitochondrial RNA. Despite the great variability of affected genes, in the most severe cases, a neuromuscular degenerative phenotype is observed, and no specific therapy exists for a complete recovery from the disease.
The most used treatments are symptomatic based on the administration of antioxidant cocktails in combination with antiepileptic/antipsychotic drugs. Unfortunately, antioxidant therapies have met limited success and it is still urgent to highlight new/real pharmacological targets and to design/identify highly selective/efficient drugs to rescue mitochondrial-impaired pathways. In this context, very little attention was dedicated to proteins responsible for the crosstalk between mitochondria and cytoplasm such as mitochondrial transporters (i.e., SLC25A family members) and FAD/NADH dehydrogenases (i.e., AIF), playing a crucial role in the maintenance of metabolites and oxidative balance, as well as in the regulation of mitochondrial apoptosis.
Prof. Pierri will discuss molecular aspects of the limited success of antioxidant therapies, and will illustrate the role of mitochondrial transporters and FAD/NADH dehydrogenases in mitochondrial function for the possible development of new MD treatments.
Join Targeting Mitochondria 2023 to learn more about Prof. Perrie's talk.
Targeting Mitochondria 2023 Congress
October 11-13, 2023 - Berlin, Germany
Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact
During the Targeting Mitochondria 2023 congress, Dr. Afshin Beheshti, Blue Marble Space Institute of Science, USA will give a presentation entitled "Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact".
Join Targeting Mitochondria 2023 to learn more about Dr. Beheshti's talk.
Targeting Mitochondria 2023 Congress
October 11-13, 2023 - Berlin, Germany
Protein Transport across Mitochondrial Membranes
Dr. Peter Rehling, from University Medical Center Göttingen, Germany will join the Targeting Mitochondria 2023 congress and present his research on "Protein Transport across Mitochondrial Membranes".
In his talk, Dr. Rehling will share his latest research on the molecular mechanisms of protein import into mitochondria, focusing on recent advances in understanding the role of protein chaperones and translocases.
Join Targeting Mitochondria 2023 to learn more about Prof. Rehling's interesting talk.
Targeting Mitochondria 2023 Congress
October 11-13, 2023 - Berlin, Germany
The role of Mitochondria in Liver Regeneration
Prof. Jiri Neuzil from Griffith University, Australia will join the Targeting Mitochondria 2023 congress which will be held on October 11-13, 2023 in Berlin, Germany, and will present a talk entitled "The role of Mitochondria in Liver Regeneration".
Prof. Neuzil focuses on the role of mitochondria in cancer. Major projects of his laboratory are mitochondria as a target for cancer therapy; horizontal transfer of mitochondria; the role of respiratory complexes in the biology and function of mitochondria; role of metabolic switch in malignant transformation and tissue regeneration. He developed a novel anti-cancer drug, mitochondrially targeted tamoxifen (MitoTam), an analogue of tamoxifen tagged with a delocalized cation (triphenylphosphonium) that preferentially targets the inner mitochondrial membrane of cancer cells, interfering with mitochondrial respiratory complex I. MitoTam has recently underwent Phase I/Ib clinical trial with efficacy against renal cell carcinoma.
Prof. Neuzil obtained his Ph.D. from the Institute of Microbiology in Prague, then he was a post-doctoral fellow at the Heart Research Institute in Sydney, Australia. After 3 years at the University of Munich as a Junior Group Leader and one year as a visiting researcher at the University of Linkoping (Sweden), he got the position of Senior lecturer in 2002 (later on Associate Professor and Professor) at Griffith University in Southport, Qld, Australia. Since 2006, he is a Group Leader at the Institute of Biotechnology, Czech Academy of Sciences in Prague. He has published over 245 scientific papers and his HI is 62.
Join Targeting Mitochondria 2023 to learn more about Prof. Neuzil's talk.
Targeting Mitochondria 2023 Congress
October 11-13, 2023 - Berlin, Germany
